Page last updated: 2024-10-31

midodrine and Brain Stem Neoplasms, Primary

midodrine has been researched along with Brain Stem Neoplasms, Primary in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research Excerpts

ExcerptRelevanceReference
"A case with dorsal medullary cavernous angioma presenting with OH is described."1.35Orthostatic hypotension associated with dorsal medullary cavernous angioma. ( Araya, P; Benarroch, E; Idiaquez, J, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Idiaquez, J1
Araya, P1
Benarroch, E1

Other Studies

1 other study available for midodrine and Brain Stem Neoplasms, Primary

ArticleYear
Orthostatic hypotension associated with dorsal medullary cavernous angioma.
    Acta neurologica Scandinavica, 2009, Volume: 119, Issue:1

    Topics: Adrenergic alpha-Agonists; Anti-Inflammatory Agents; Ataxia; Brain Stem Neoplasms; Female; Fludrocor

2009